跳至主要内容
临床试验/ACTRN12623000093684
ACTRN12623000093684招募中未知

Clinical, radiographic and patient-reported outcomes using MobiliT™ cup with ECiMa™ insert in primary total hip arthroplasty surgery.

Corin Australia Pty Limited0 个研究点目标入组 100 人开始时间: 2023年1月27日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • The individual has signed a Patient Informed Consent Form (PICF), specific to this clinical investigation, and approved by the Human Research Ethics Committee.
  • - Both genders.
  • - Minimum age 18 years old, maximum age of 85 years old.
  • - The individual clinically qualifies for a dual mobility total hip arthroplasty surgery with MobiliT™ ECiMa cup and Paragon stem based on physical examination and medical history and has been scheduled for surgery.
  • - The individual is willing to comply with the required protocol for follow-up visits.

排除标准

  • - Individuals under guardianship.
  • - Individuals with any physical or psychological condition which would impair clinical investigation participation.
  • - Individual with current hip infection.
  • - Any patient pregnant or with plans to become pregnant during the clinical study.
  • - Individuals who are already enrolled in other clinical studies.

研究者

相似试验